Work Experience:
• Since 2015:Director of the Department of Gynecology and Obstetrics, Ludwig-Maximilian-University Munich, Germany
• 2012-2015:Associate Director Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
• 2009-2012:Senior Consultant Gynecologic Oncology at the University Medical Center Hamburg-Eppendorf, Hamburg, Germany
• 2003- 2008:Residency Gynecology and Obstetrics, University Hospital Hamburg-Eppendorf
Awards:
• 荣登FOCUS“顶级医生”排行榜
• 2012:Staude-Pfannenstiel Award, North German Society of Gynecology And Obstetrics
• 2010:Niall O’Higgins Award, European Society of Surgical Oncology
• 2009:Georg-Ernst-Konjetzny-Award of Hamburg Cancer Society
• 2009:ASCO Merit Award der American Society of Clinical Oncology
• 2009:Award for transnational research, Working Group "Gynecological Oncology" (Senior)
• 2006:Poster Award, North German Society of Gynecology And Obstetrics
Memberships:
• American Society of Clinical Oncology (ASCO)
• Study group, Steering committee, ovarian cancer board and executive board of the German Society of Gynecologic Oncology (AGO-Germany)
• German Society of Gynecology and Obstetrics (DGGG)
• German Cancer Society (DKG)
• European Society of Gynecologic Oncology
• Obstetrics Society of Hamburg
• International Academy of Life Sciences (IALS)
• International Gynecologic Cancer Society (IGCS)
• North German Society of Gynecology and Obstetrics (NGGG)
• North-Eastern German Society of Gynecologic Oncology (NOGGO)Publications:
2020年2月 《细胞质PPARγ是COX-1阴性乳腺癌患者损坏损坏的标志》
2020年2月 《p16阴性和阳性外阴鳞状细胞癌中PD-L1的表达及生存率》
2020年1月 《原发性乳腺癌中甲状腺激素受体β1的胞质和核型与生存率呈负相关》
2019年 11月 《多中心/多灶与单灶乳腺癌中激素受体的表达:特别是VDR决定了与病灶相关的结果》
2019年7月 《EP3受体拮抗剂l798106抑制SK-BR-3乳腺癌细胞的增殖和迁移》